
Quick Study.
Let’s get right to the point.
No one has time to wait for answers. That’s why we developed QScout® RLD (Rapid Leukocyte Differential). It reports a white blood cell and differential count at patient-side in about 2 minutes from a drop of blood. Results include immature infection-fighting cells some labs count manually.
News that counts.
AAD awarded BARDA contract to develop next gen CBC, sepsis diagnostic system
​
​AAD, developer of rapid diagnostic and data systems, today announced that it has been awarded a federal contract of $5 million with potential to award up to $12.6 million for the development of an improved diagnostic system designed to deliver faster complete blood count (CBC) test results and the earlier detection of severe infection, including sepsis.
​

Forget the hassle.
QScout® RLD requires no lengthy machine startup time or sample prep. No wet reagents that need to be changed or disposed. No pumps. Only a drop of blood. It goes from powered off to your first result in about 3 minutes. It’s easy to use with minimal training.

See the difference.
It’s an imaging-based system not prone to the challenges of flow cytometry or the Coulter Principle. Cells are examined directly by a trained computer using AI instead of indirect measures like light scatter or electrical resistance.
If you’re an investigator interested in clinical trials, please contact us.
​
​